CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience
Abstract Background The usefulness of the CHA2DS2-VASC risk score (CVRS) in predicting the occurrence of contrast-induced nephropathy (CIN) among patients with chronic total occlusion (CTO) undergoing percutaneous coronary intervention (PCI) remains unclear. Method A total of 239 patients with CTO w...
Main Authors: | Yong Wang, Hong-wei Zhao, Xiao-jiao Zhang, Bao-jun Chen, Guo-ning Yu, Ai-jie Hou, Bo Luan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-019-1060-0 |
Similar Items
-
Value of the CHA2DS2‐VASc score for predicting outcome in patients with heart failure
by: Mony Shuvy, et al.
Published: (2020-10-01) -
CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention
by: Fardin Mirbolouk, et al.
Published: (2018-03-01) -
The CHA2DS2-VASc score and in-hospital mortality in patients with COVID-19: A multicenter retrospective cohort study
by: Alaa Quisi, et al.
Published: (2020-10-01) -
The relationship of the serum endocan level with the CHA2DS2-VASc score in patients with paroxysmal atrial fibrillation
by: Gökhan Ceyhun
Published: (2021-01-01) -
CHA2DS2-VAS-HSF Score as a Predictor for Contrast- Induced Nephropathy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
by: Herman William Parlindungan, et al.
Published: (2019-09-01)